Mice from ischemia transplantation isogeneic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Myocardium Transplants Liver Hindlimb Kidney Heart Brain Antilymphocyte Serum Cells, Cultured Hematopoietic Stem Cells Stem Cells Bone Marrow Cells T-Lymphocytes Portal Vein Neurons Hepatic Artery Leg Fetal Blood Bone Marrow Lower Extremity Myocytes, Cardiac Allografts Hippocampus

Organisms13

Transplantation Chimera Rats, Sprague-Dawley Mice, Inbred C57BL Rats, Wistar Gerbillinae Rats, Inbred Lew Dogs Swine Mice, Knockout Rabbits Mice, Inbred BALB C Mice, Transgenic Chimera

Diseases52

Ischemia Myocardial Ischemia Brain Ischemia Reperfusion Injury Graft vs Host Disease Myocardial Reperfusion Injury Postoperative Complications Liver Failure Disease Models, Animal Recurrence Ischemic Attack, Transient Hematologic Neoplasms Cadaver Liver Diseases Acute Disease Spinal Cord Ischemia Kidney Failure, Chronic Infarction, Middle Cerebral Artery Leukemia Bronchiolitis Obliterans Brain Death Myocardial Infarction Anemia, Aplastic Blood Group Incompatibility Cytomegalovirus Infections Cerebral Infarction End Stage Liver Disease Primary Graft Dysfunction Delayed Graft Function Liver Failure, Acute Coronary Disease Multiple Myeloma Liver Cirrhosis Necrosis Chronic Disease Leukemia, Myeloid, Acute Infection Biliary Atresia Arterial Occlusive Diseases Lymphoma, Non-Hodgkin Hepatic Veno-Occlusive Disease Liver Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Kidney Diseases Brain Edema Lymphoproliferative Disorders Mesenteric Vascular Occlusion Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Hematologic Diseases Carcinoma, Hepatocellular Death

Chemicals and Drugs26

Niridazole Immunosuppressive Agents Tacrolimus Cyclosporine Busulfan Neuroprotective Agents HLA Antigens Antilymphocyte Serum Mycophenolic Acid Myeloablative Agonists Cyclophosphamide Organ Preservation Solutions Biological Markers Melphalan ABO Blood-Group System Cardiotonic Agents Antigens, CD34 Isoantibodies Granulocyte Colony-Stimulating Factor Vidarabine Creatinine Azathioprine Raffinose Cyclosporins Antibodies, Monoclonal Adenosine

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Transplantation, Isogeneic Transplantation, Homologous Liver Transplantation Neoplasm Transplantation Kidney Transplantation Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Organ Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Cell Transplantation Transplantation, Heterotopic Treatment Outcome Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Warm Ischemia Retrospective Studies Cold Ischemia Peripheral Blood Stem Cell Transplantation Reperfusion Immunosuppression Histocompatibility Testing Fetal Tissue Transplantation Disease Models, Animal Skin Transplantation Mesenchymal Stem Cell Transplantation Follow-Up Studies Transplantation, Heterologous Ischemic Preconditioning Organ Preservation Corneal Transplantation Tissue Transplantation Survival Rate Survival Analysis Whole-Body Irradiation Brain Tissue Transplantation Facial Transplantation Donor Selection Risk Factors Ischemic Preconditioning, Myocardial Prospective Studies Prognosis Combined Modality Therapy Myocardial Reperfusion Postoperative Period Tissue and Organ Harvesting Models, Animal Remission Induction Patient Selection Hand Transplantation Perfusion Immunohistochemistry Disease-Free Survival Anastomosis, Surgical Biopsy Incidence Risk Assessment Fatal Outcome Hematopoietic Stem Cell Mobilization Reoperation Actuarial Analysis Severity of Illness Index Kaplan-Meier Estimate Hepatectomy Lymphocyte Transfusion Lymphocyte Depletion Electrocardiography Multivariate Analysis Exercise Test Predictive Value of Tests Postoperative Care Constriction Antineoplastic Combined Chemotherapy Protocols Random Allocation Salvage Therapy Heart-Assist Devices Flow Cytometry Blood Pressure Analysis of Variance Cohort Studies Cell Count Cryopreservation Proportional Hazards Models Tissue Preservation Feasibility Studies Preoperative Care Hypothermia, Induced Liver Function Tests

Psychiatry and Psychology1

Phenomena and Processes30

Graft Survival Graft Rejection Transplantation Immunology Time Factors Transplantation Tolerance Histocompatibility Cerebrovascular Circulation Hemodynamics Coronary Circulation Cell Differentiation Neovascularization, Physiologic Recovery of Function Necrosis Chimerism Apoptosis Graft vs Leukemia Effect Cell Survival Myocardial Contraction Graft vs Tumor Effect Hematopoiesis Regeneration Regional Blood Flow Ventricular Function, Left Blood Pressure Cell Death Liver Circulation Cell Count Dose-Response Relationship, Drug Graft vs Host Reaction Immune Tolerance

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science3

Survival Rate Incidence Fatal Outcome

Named Groups4

Tissue Donors Living Donors Unrelated Donors Siblings

Health Care29

Treatment Outcome Retrospective Studies Tissue and Organ Procurement Follow-Up Studies Waiting Lists Survival Rate Survival Analysis Donor Selection Risk Factors Prospective Studies Postoperative Period Patient Selection Disease-Free Survival Incidence Risk Assessment Fatal Outcome Actuarial Analysis Severity of Illness Index Kaplan-Meier Estimate Multivariate Analysis Predictive Value of Tests Postoperative Care Random Allocation Analysis of Variance Age Factors Cohort Studies Proportional Hazards Models Feasibility Studies Preoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Transplantation, Isogeneic Niridazole Transplantation, Homologous Ischemia Liver Transplantation Neoplasm Transplantation Kidney Transplantation Myocardial Ischemia Brain Ischemia Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Graft Survival Organ Transplantation Graft Rejection Pancreas Transplantation Reperfusion Injury Tissue Donors Islets of Langerhans Transplantation Transplantation Transplantation Immunology Cell Transplantation Transplantation Chimera Time Factors Immunosuppressive Agents Graft vs Host Disease Living Donors Transplantation, Heterotopic Treatment Outcome Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Warm Ischemia Retrospective Studies Tissue and Organ Procurement Myocardial Reperfusion Injury Transplantation Tolerance Cold Ischemia Peripheral Blood Stem Cell Transplantation Postoperative Complications Reperfusion Liver Failure Immunosuppression Histocompatibility Testing Fetal Tissue Transplantation Disease Models, Animal Recurrence Ischemic Attack, Transient Skin Transplantation Mesenchymal Stem Cell Transplantation Follow-Up Studies Waiting Lists Transplantation, Heterologous Tacrolimus Ischemic Preconditioning Organ Preservation Corneal Transplantation Histocompatibility Cyclosporine Myocardium Hematologic Neoplasms Tissue Transplantation Survival Rate Survival Analysis Rats, Sprague-Dawley Cadaver Whole-Body Irradiation Mice, Inbred C57BL Liver Diseases Rats, Wistar Acute Disease Gerbillinae Brain Tissue Transplantation Spinal Cord Ischemia Facial Transplantation Donor Selection Risk Factors Transplants Busulfan Ischemic Preconditioning, Myocardial Kidney Failure, Chronic Prospective Studies Liver Rats, Inbred Lew Infarction, Middle Cerebral Artery Neuroprotective Agents Prognosis HLA Antigens Combined Modality Therapy Leukemia Myocardial Reperfusion Postoperative Period Hindlimb Kidney Bronchiolitis Obliterans Tissue and Organ Harvesting Heart

No FAQ available that match "mice from ischemia transplantation isogeneic"